Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000277.3(PAH):c.1117G>A (p.Ala373Thr)

CA229351

102529 (ClinVar)

Gene: PAH (HGNC:5053)

Condition: phenylketonuria (MONDO:0009861)

Inheritance Mode: Autosomal recessive inheritance

UUID: 8686a349-d7cd-48e5-8286-1fc2466ab98c

Approved on: 2022-06-12

Published on: 2022-06-12

HGVS expressions

NM_000277.3(PAH):c.1117G>A (p.Ala373Thr)

NM_000277.3:c.1117G>A

NC_000012.12:g.102843728C>T

CM000674.2:g.102843728C>T

NC_000012.11:g.103237506C>T

CM000674.1:g.103237506C>T

NC_000012.10:g.101761636C>T

NG_008690.1:g.78875G>A

NG_008690.2:g.119683G>A

ENST00000553106.6:c.1117G>A

ENST00000307000.7:c.1102G>A

ENST00000549247.6:n.876G>A

ENST00000551114.2:n.779G>A

ENST00000553106.5:c.1117G>A

ENST00000635477.1:n.221G>A

ENST00000635528.1:n.632G>A

NM_000277.1:c.1117G>A

NM_000277.2:c.1117G>A

NM_001354304.1:c.1117G>A

NM_001354304.2:c.1117G>A

Likely Pathogenic

PM3 PM2 PP4_Moderate

PP3 PM5 PS3

Evidence Links 1

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.1117G>A (p.Ala373Thr) variant in PAH has been reported in multiple individuals with mild HPA (BH4 deficiency excluded, PP4_Moderate). This variant is absent in population databases (PM2). This variant was detected with pathogenic variants c.442-1G>A (PMID: 10484807) and in trans with p.Arg261Gln (PMID: 29316886). Computational evidence is conflicting. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PP4_Moderate, PM2, PM3.

PM3

detected with IVS4-1G>A. parental analysis not reported PMID: 10484807; detected in trans with p.Arg261Gln (P, 9 submitters) PMID: 29316886

PM2

Absent from controls in ExAC, gnomAD, 1000 Genomes, ESP

PP4_Moderate

detected in a patient with mild HPA (4 mg/dL). BH4 deficiency excluded by urinary pteridine HPLC and DHPR activity. PMID: 10484807

PP3

Computational evidence is conflicting: Deleterious in SIFT, MutationTaster; Benign in PolyPhen2-HVAR, REVEL=0.739.

PM5

A373D Likely pathogenic

PS3

Residual activity in prokaryotic system (56%) PMID: 16091306

Residual activity in prokaryotic system (56%); Hill coefficient 1.8; binding affinity for L-Phe of PAH mutant protein (144+/- 14) PubMed:16091306

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.